• 구독신청
  • My스크랩
  • 지면신문
FNTIMES 대한민국 최고 금융 경제지
ad

'Solid Performance Amidst Recession' - S-Oil · GS Caltex, What’s Their Secret?

곽호룡 기자

horr@fntimes.com

기사입력 : 2025-02-20 10:53

- GS Caltex surpasses 25% Operating Margin in Lubricants
- S-OIL Accelerates 'Shaheen Project' to Strengthen Petrochemical Sector
- SK Innovation-HD Hyundai Oilbank, business diversification sluggish

[Korea Financial Times, Gwak Horyung] Despite the economic downturn last year, GS Caltex and S-OIL managed to differentiate themselves by leveraging their lubricant and petrochemical divisions, respectively.

The combined annual operating profit of South Korea’s four major refiners stood at approximately KRW 1.58 trillion in 2024, a sharp decline to nearly one-third of the KRW 4.47 trillion recorded in 2023.

Looking back over the past year, all four companies were in the red in the wake of the economic slowdown that began in earnest in the second quarter and the plunge in oil prices in the third quarter, before rebounding in the fourth quarter on the back of a recovery driven by winter heating demand.

'Solid Performance Amidst Recession' - S-Oil · GS Caltex, What’s Their Secret?
Graphic & Table Creation=Korea Financial Times / Data Source=Each company

Graphic & Table Creation=Korea Financial Times / Data Source=Each company


GS Caltex Leads the Industry in Profitability ... S-OIL Invests in Petrochemical Expansion

GS Caltex recorded the highest operating profit among its peers, posting KRW 548 billion. The company’s lubricant business has consistently delivered strong margins, standing out from competitors. While rivals in the sector maintain an average operating margin of around 15%, GS Caltex surpassed 25%. This success is attributed to the company’s strategic focus on high-value automotive lubricant finished products.

S-OIL recorded the highest operating margin (1.3%) among the four major refiners. Although it was the only company in the sector to post a deficit in its refining operations, its relatively strong performance in the struggling petrochemical sector helped offset losses. It was the only one of the four to post a loss in its refining business, but it offset this with relatively solid profitability in petrochemicals, where all were struggling.

S-Oil plans to start the Shahine Project in Ulsan in 2026, investing KRW 9 trillion to build a large-scale petrochemical complex. It is expected that the project will disrupt the domestic petrochemical landscape, leveraging the raw material prices and technological competitiveness of its parent company, Saudi Aramco. S-OIL plans to nearly double the proportion of its revenue derived from petrochemicals, increasing it from the current 12-13%.

* Excluding consolidation adjustments such as HD Hyundai Oil Bank's internal transactions / Data Source=Each company

* Excluding consolidation adjustments such as HD Hyundai Oil Bank's internal transactions / Data Source=Each company

이미지 확대보기

HD Hyundai Oilbank and SK Innovation Face Challenges

HD Hyundai Oilbank struggled due to setbacks in its petrochemical business. Its joint venture with Lotte Chemical, HD Hyundai Chemical, posted an operating loss of KRW 70 billion.

Meanwhile, SK Innovation delivered relatively stable results in its traditional oil-based businesses. However, it suffered a substantial KRW 1.4 trillion deficit in its battery and battery materials divisions. The company did alleviate some financial pressure through its Q4 merger with E&S.

Outlook for 2025: Cautious Optimism Amid Global Uncertainty

The industry outlook for this year is expected to be similar to last year. Global economic sluggishness and stable international oil prices are anticipated to continue.

There is, however, a variable: former U.S. President Donald Trump. The domestic industry holds mixed feelings of “half expectation, half concern.”

If the Trump administration enforces a policy of strengthening tariffs, it could have a positive impact on the domestic refining industry. The increase in the proportion of expensive U.S. refineries could raise margins for oil products overall. However, uncertainty surrounding implementation and potential side effect of a global trade reduction make it difficult to gauge the actual impact on the industry.

Gwak Horyung (horr@fntimes.com)

데일리 금융경제뉴스 FNTIMES - 저작권법에 의거 상업적 목적의 무단 전재, 복사, 배포 금지
Copyright ⓒ 한국금융신문 & FNTIMES.com

가장 핫한 경제 소식! 한국금융신문의 ‘추천뉴스’를 받아보세요~

KFT Topic 다른 기사

1 LG Chem Petrochemicals Face Losses Despite NCC Restart; Advanced Materials Recovering Petrochemicals is once again LG Chem’s main concern. While earnings at its battery subsidiary and advanced materials business are improving, its petrochemicals division, which returned to profit in the first half, is expected to slip back into the red in the second half. The No. 2 naphtha cracking center (NCC) plant in Yeosu, idled for about six months, has resumed operations. But a profit recovery looks difficult as the negative inventory lag effect from falling feedstock prices and higher logistics costs weigh on results.According to financial data provider FnGuide on the 22th, the consensu 2 Hanwha Systems Raises KRW 3.4 Trillion as It Winds Down ‘Bridge’ Role in Hanwha Ocean Deal Hanwha Systems is raising KRW 3.4 trillion through a price return swap (PRS) on its Hanwha Ocean shares and the sale of its stake in the Philly shipyard in the United States. Both assets came out of Hanwha Systems’ efforts to back the Hanwha Group’s push to strengthen its shipbuilding business. The company is now expected to end its “bridge” role and concentrate on strengthening its core business through capital reallocation.According to the investment banking (IB) industry on Oct. 20, Hanwha Systems recently decided to transfer all 22,169,660 of its Hanwha Ocean common shares to Kiwoom Se 3 Hanmi Pharm Hit by Shareholder Feud, Rights Return; Next Obesity Drug Key to Rebound Hanmi Pharm is facing a double blow, a dispute among its major shareholders and the return of rights to a key pipeline asset, and has slipped into a valuation discount.While solid core profitability provides a cushion, further out-licensing of follow-up obesity drugs and a resolution of governance risk are expected to be the main turning points for a revaluation.Inheritance Tax Sparked the Feud, Now a KRW 60 Billion LawsuitHanmi Pharmaceutical Group’s operating environment is clouded from every direction, industry sources said on Oct. 18. The governance risk began after the death of founder L
ad
ad
ad

한국금융 포럼 사이버관

더보기

FT카드뉴스

더보기
[그래픽 뉴스] ‘순대’가 경제용어라고? 순(純)대외자산, 한국의 진짜 해외자산은 얼마일까?
[그래픽 뉴스] ISA 대개편! 나에게 유리한 계좌는?
[그래픽 뉴스] 미국 증시 새로운 키워드 'MANGOS'
환전·로또·육아휴직까지 하반기부터 달라지는 제도 TOP11
[그래픽 뉴스] 은퇴후 30년 부모님 세대의 생존전략

FT도서

더보기